Aldagen, Inc.

Aldea Pharmaceuticals will begin clinical trials in acute alcohol intoxication and Fanconi anemia for AD-6626, the company's lead drug candidate for aldehyde metabolism disorders, with $24m in Series

Cytomedix is to downsize its R&D activities in a renewed focus on profitability, in what is its second reorganization in as many months. As part of its latest initiative, the company's will "substanti

Cytomedix stock lost 25% of its value on 20 February when the Gaithersburg, Maryland-based company specializing in autologous regenerative therapies announced three different financing vehicles design

IN VITRO DIAGNOSTICS Mergers & Acquisitions Signal Genetics LLC ChipDx LLC Predictive testing company Signal Genetics Inc. has acquired privately held ChipDX LLC (molecular diagnostics for can